Tag: Healthcare regulations
GLP-1 Compounding: The Final Chapter
So, like, you wanna keep up with all the cool stuff happening in biotech, right? Well, sign up for our biotech newsletter and get all the juicy deets straight to your inbox. Trust me,...
RFK Jr.’s Stem Cell Deregulation Roundtable: Red Flags Raised
Renowned cell biology and human anatomy professor at UC Davis School of Medicine, Paul Knoepfler, introduces a new column, Lab Dish, focusing on regenerative medicine. The recent roundtable on regenerative medicine hosted by Health...
NIH Patent Freeze, Senate Hearing for FDA Chief: Pharmalittle Update
The National Institutes of Health (NIH) technology transfer offices have hit a roadblock, halting the filing of new patent applications and restricting the licensing of existing ones for the past five weeks, as reported...
Telehealth Rules for Adderall, Buprenorphine, and Controlled Meds: DEA Guidelines
DEA Introduces New Telehealth Rules for Controlled SubstancesThe Drug Enforcement Administration (DEA) has finally unveiled a long-awaited announcement regarding the prescription of controlled substances through telemedicine. This groundbreaking move comes after a 16-year delay...
Former Hahn Adviser Joins Trump’s FDA Transition Team with Top Capitol Hill Aide
Former Hahn Adviser Joins Trump's FDA Transition Team with Top Capitol Hill AideIn a strategic move signaling the early efforts of President-elect Trump's team to bolster the Food and Drug Administration (FDA) transition team...
South African Regulator’s Decision on Vertex CF Drugs Access Angers Activists
South African Regulator's Decision on Vertex CF Drugs Access Angers ActivistsAfter a thorough investigation, South African regulators have concluded that Vertex Pharmaceuticals has met the criteria for providing access to its cystic fibrosis medications....
U.K. Restricts Lilly’s Obesity Drug, Pharma Layoffs, and More: Pharmalittle Update
U.K. Restricts Lilly's Obesity Drug to Those in Greatest NeedIn a move to adapt to the rising demand for obesity treatment, the U.K. announced that it will be offering Eli Lilly's weight loss drug,...
U.K. Tightens Restrictions on Eli Lilly’s Obesity Drug for High-Need Patients
U.K. to Restrict Eli Lilly's Obesity Drug for High-Need PatientsLONDON - In a bid to address the rising demand for obesity treatment, the U.K. has announced plans to introduce Eli Lilly's weight loss drug,...
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news. Today, we have some updates on Novo Nordisk and Amgen...
BREAKING NEWS
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee...
